• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常人脾脏及尼曼-匹克病患者脾脏中的鞘磷脂酶

Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease.

作者信息

Schneider P B, Kennedy E P

出版信息

J Lipid Res. 1967 May;8(3):202-9.

PMID:4962590
Abstract

This paper describes the purification and some of the properties of an enzyme from human spleen that catalyzes the hydrolysis of sphingomyelin with the formation of ceramide and phosphoryl choline. The enzyme, which is located in the subcellular particulate fraction that sediments between 700 and 8500 g, is readily made soluble and has been partially purified. Its pH optimum is between 4.5 and 5.0. It is unaffected by divalent cations, chelating agents, and sulfhydryl reagents, but is inhibited by phosphate. The enzyme attacks sphingomyelin and dihydrosphingomyelin, but is inactive toward sphingosine phosphoryl choline, O-acetylsphingomyelin, and lecithin. In some of its properties, the enzyme from human spleen is different from the previously studied sphingomyelinase from rat tissues. The enzyme is absent or markedly reduced in spleens from patients with classical and visceral varieties of Niemann-Pick disease, but is present in normal amounts in the late infantile type of the disease. In the present study another enzyme, this one magnesium-dependent, capable of catalyzing the cleavage of sphingomyelin has been detected in the spleens of patients with the classical form of Niemann-Pick disease. Some implications of these findings for theories of the metabolic defect in Niemann-Pick disease are discussed.

摘要

本文描述了一种从人脾脏中提取的酶的纯化过程及其一些特性,该酶催化鞘磷脂水解生成神经酰胺和磷酸胆碱。这种酶位于亚细胞颗粒组分中,在700至8500克离心力下沉淀,很容易溶解并已得到部分纯化。其最适pH值在4.5至5.0之间。它不受二价阳离子、螯合剂和巯基试剂的影响,但受磷酸盐抑制。该酶作用于鞘磷脂和二氢鞘磷脂,但对鞘氨醇磷酸胆碱、O - 乙酰鞘磷脂和卵磷脂无活性。在某些特性方面,人脾脏中的这种酶与先前研究的大鼠组织鞘磷脂酶不同。在经典型和内脏型尼曼 - 匹克病患者的脾脏中,这种酶缺失或明显减少,但在晚婴儿型疾病中含量正常。在本研究中,在经典型尼曼 - 匹克病患者的脾脏中检测到另一种酶,这种酶依赖镁,能够催化鞘磷脂的裂解。讨论了这些发现对尼曼 - 匹克病代谢缺陷理论的一些影响。

相似文献

1
Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease.正常人脾脏及尼曼-匹克病患者脾脏中的鞘磷脂酶
J Lipid Res. 1967 May;8(3):202-9.
2
Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.尼曼-匹克病C型:刺激鞘磷脂和葡萄糖脑苷脂降解的激活因子缺乏的证据
Hoppe Seylers Z Physiol Chem. 1980 Oct;361(10):1489-502. doi: 10.1515/bchm2.1980.361.2.1489.
3
Enzyme activities and phospholipid storage patterns in brain and spleen samples from Niemann-Pick disease variants: a comparison of neuropathic and non-neuropathic forms.尼曼-匹克病变体脑和脾样本中的酶活性及磷脂储存模式:神经病变型与非神经病变型的比较
J Inherit Metab Dis. 1986;9(1):59-71. doi: 10.1007/BF01813904.
4
Quantitative evaluation of sphingomyelin and glucosylceramide using matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to tissues from patients with Niemann-Pick disease types A and C, and Gaucher disease.以鞘氨醇磷酸胆碱为内标,使用基质辅助激光解吸电离飞行时间质谱对鞘磷脂和葡萄糖神经酰胺进行定量评估。在A型和C型尼曼-匹克病以及戈谢病患者组织中的实际应用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jul 15;870(2):170-6. doi: 10.1016/j.jchromb.2008.05.013. Epub 2008 May 16.
5
Degradation of fluorescent and radiolabelled sphingomyelins in intact cells by a non-lysosomal pathway.完整细胞中荧光和放射性标记鞘磷脂通过非溶酶体途径的降解
Biochim Biophys Acta. 1995 Oct 5;1258(3):277-87. doi: 10.1016/0005-2760(95)00132-v.
6
Studies on the activation of the enzymatic hydrolysis of sphingomyelin liposomes.鞘磷脂脂质体酶促水解的激活研究。
Biochim Biophys Acta. 1984 Apr 18;793(2):141-8. doi: 10.1016/0005-2760(84)90315-1.
7
Lysosomal involvement in cellular turnover of plasma membrane sphingomyelin.溶酶体参与质膜鞘磷脂的细胞更新。
Biochim Biophys Acta. 1984 Apr 18;793(2):169-79. doi: 10.1016/0005-2760(84)90318-7.
8
Enzymatic hydrolysis of sphingomyelin liposomes by normal tissues and tissues from patients with Niemann-Pick disease.正常组织和尼曼-匹克病患者组织对鞘磷脂脂质体的酶促水解作用。
Biochim Biophys Acta. 1983 May 16;751(3):428-31. doi: 10.1016/0005-2760(83)90302-8.
9
Sphingomyelin and glucocerebroside of spleen in cases of Gaucher's and Niemann-Pick's diseases.戈谢病和尼曼-匹克病患者脾脏中的鞘磷脂和葡萄糖脑苷脂。
Jpn J Exp Med. 1967 Oct;37(5):505-9.
10
Uptake and metabolism of radioactively labeled sphingomyelin in cultured skin fibroblasts from controls and patients with Niemann-Pick disease and other lysosomal storage diseases.来自对照个体以及患有尼曼-匹克病和其他溶酶体贮积病患者的培养皮肤成纤维细胞中放射性标记鞘磷脂的摄取与代谢
Biochim Biophys Acta. 1983 Nov 1;754(1):82-92. doi: 10.1016/0005-2760(83)90084-x.

引用本文的文献

1
Neutral sphingomyelinase 2: A promising drug target for CNS disease.中性鞘磷脂酶2:中枢神经系统疾病的一个有前景的药物靶点。
Adv Pharmacol. 2025;102:65-101. doi: 10.1016/bs.apha.2024.10.015. Epub 2024 Oct 28.
2
A Brief Overview of the Toxic Sphingomyelinase Ds of Brown Recluse Spider Venom and Other Organisms and Simple Methods To Detect Production of Its Signature Cyclic Ceramide Phosphate.褐隐士蜘蛛毒液及其他生物中的毒性鞘磷脂酶Ds概述以及检测其标志性环磷酸神经酰胺产生的简单方法。
Mol Pharmacol. 2024 Feb 15;105(3):144-154. doi: 10.1124/molpharm.123.000709.
3
Apolipoprotein-mimetic nanodiscs reduce lipid accumulation and improve liver function in acid sphingomyelinase deficiency.
载脂蛋白模拟纳米盘可减少酸性鞘磷脂酶缺乏症患者的脂质积累并改善肝功能。
Nanomedicine. 2023 Sep;53:102705. doi: 10.1016/j.nano.2023.102705. Epub 2023 Aug 24.
4
Plasma lipidomic profile of depressive symptoms: a longitudinal study in a large sample of community-dwelling American Indians in the strong heart study.社区居住的美国印第安人群体中抑郁症状的血浆脂质组学特征:一项在“强壮心灵研究”中的大样本的纵向研究。
Mol Psychiatry. 2023 Jun;28(6):2480-2489. doi: 10.1038/s41380-023-01948-w. Epub 2023 Jan 19.
5
Involvement of Ceramide Signalling in Radiation-Induced Tumour Vascular Effects and Vascular-Targeted Therapy.涉及神经酰胺信号在放射诱导的肿瘤血管效应和血管靶向治疗中的作用。
Int J Mol Sci. 2022 Jun 15;23(12):6671. doi: 10.3390/ijms23126671.
6
Acid sphingomyelinase/ceramide system in schizophrenia: implications for therapeutic intervention as a potential novel target.精神分裂症中的酸性鞘磷脂酶/神经酰胺系统:作为潜在的新型治疗靶点的治疗干预意义。
Transl Psychiatry. 2022 Jun 23;12(1):260. doi: 10.1038/s41398-022-01999-7.
7
Ceramide and Related Molecules in Viral Infections.神经酰胺及相关分子在病毒感染中的作用
Int J Mol Sci. 2021 May 26;22(11):5676. doi: 10.3390/ijms22115676.
8
mRNA Expression of Encoding Acid Sphingomyelinase Decreases upon Antidepressant Treatment.编码酸性鞘磷脂酶的mRNA表达在抗抑郁治疗后降低。
Int J Mol Sci. 2021 May 27;22(11):5700. doi: 10.3390/ijms22115700.
9
Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases.扼杀疾病于萌芽状态:nSMase2 抑制剂作为细胞外囊泡介导疾病的治疗方法。
Drug Discov Today. 2021 Jul;26(7):1656-1668. doi: 10.1016/j.drudis.2021.03.025. Epub 2021 Mar 31.
10
Neutral sphingomyelinase-2 and cardiometabolic diseases.中性鞘磷脂酶 2 与心脏代谢疾病。
Obes Rev. 2021 Aug;22(8):e13248. doi: 10.1111/obr.13248. Epub 2021 Mar 18.